A rapid diagnostic test for detecting SARS-CoV-2 and future variants at the point of care. Plays a crucial role in infection control and prevention of viral spread.
Manufactured by
Singapore, Singapore
Today, doctors face the delicate challenge of making accurate diagnoses daily. However, the tools currently available to them are far from perfect. Medical practitioners often find themselves having to compromise between performance and convenience. Since 2011, Credo Diagnostics has been researching and developing revolutionary diagnostic technologies. Our mission is to create, manufacture, and commercialize accurate, rapid, and affordable molecular diagnostic platforms that can be used at Point-of-Care. We understand the importance of simplifying processes and speeding up diagnostic turnaround times, all while keeping costs low and ensuring the highest level of accuracy. That s why we provide innovative solutions for diagnosis in the field of Human Health. As a diagnostic company, we believe we have a moral responsibility and duty to doctors and patients. We strive to provide effective and rapid Point-of-Care Molecular Diagnostics that will redefine healthcare and revolutionize human clinical management. Credo Diagnostics is committed to improving the tools available to doctors, enabling them to make more accurate diagnoses efficiently and affordably. We are dedicated to advancing healthcare through our innovative molecular diagnostic platforms, ultimately enhancing patient care and outcomes.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Deaou Gene Technology Co.,Ltd
China · 1 relevant product
Hangzhou AllTest Biotech Co.,Ltd
China · 2 relevant products
KogeneBiotech Co., Ltd.
South Korea · 1 relevant product
Applied Biocode, Inc.
United States · 1 relevant product
VITASSAY HEALTHCARE S.L.
Spain · 2 relevant products
SeeGene Middle East FZE
South Korea · 1 relevant product
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept
India · 1 relevant product
DIA.PRO Diagnostic BioProbes Srl
Italy · 2 relevant products
Sentinel CH. SpA
Italy · 1 relevant product
Henan Million Medical Electronics Co., Ltd.
China · 1 relevant product
82 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 109 closest product alternatives
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for SARS-CoV-2 detection with high sensitivity and specificity. Delivers reliable results for COVID-19 diagnosis in clinical and point-of-care settings.
Hangzhou AllTest Biotech Co.,Ltd · China
A real-time quantitative PCR assay for the detection and quantification of SARS-CoV-2 in human samples.
KogeneBiotech Co., Ltd. · South Korea
Real-time PCR molecular diagnostic test for detection of SARS-CoV-2 virus. This assay enables rapid identification of COVID-19 infection through quantitative PCR methodology. The test was among the first developed and supplied in Korea.
Applied Biocode, Inc. · United States
Molecular diagnostic assay for detection of SARS-CoV-2. FDA-cleared in vitro diagnostic test providing reliable identification of COVID-19 infection.
VITASSAY HEALTHCARE S.L. · Spain
Quantitative PCR assay technology providing automation for quantitative, accurate, and reproducible diagnostic results. Available in lyophilized format for enhanced stability and reliability in pathogen detection.
SeeGene Middle East FZE · South Korea
A diagnostic assay for the detection of SARS-CoV-2, the virus responsible for COVID-19. This assay is part of the Allplex™ product line for respiratory infection testing.
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept · India
Real-time PCR assay for qualitative detection of SARS-CoV-2 nucleic acid in respiratory samples. Provides rapid identification of COVID-19 infection for clinical diagnosis.
DIA.PRO Diagnostic BioProbes Srl · Italy
A PCR-based diagnostic test for the detection of SARS-CoV-2. This molecular assay is designed for accurate identification of COVID-19 infection in clinical samples.
Sentinel CH. SpA · Italy
SENTiNAT® 200 is a real-time PCR assay reagent kit for molecular detection of viral pathogens including SARS-CoV-2 and other clinically relevant viruses. This in-vitro diagnostic product enables rapid, multiplex viral identification in clinical laboratory settings, delivering reliable results for infectious disease diagnosis.
Henan Million Medical Electronics Co., Ltd. · China
Rapid antigen or antibody detection assay for SARS-CoV-2 identification. Results within 15-30 minutes for screening and diagnostic purposes.
CORIS BIOCONCEPT SRL · Belgium
An RT-LAMP (Reverse Transcription Loop-mediated isothermal Amplification) assay for the detection of SARS-CoV-2 coronavirus using fluorometric detection with a DNA intercalating agent.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplexed rapid diagnostic test for the simultaneous detection and differentiation of Influenza A, Influenza B, and SARS-CoV-2 antigens. The test enables comprehensive respiratory pathogen screening in a single assay.
97 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products